Table 2.
Details of the chemotherapy regimens and number of cycles between patients with and without LS
| Chemotherapy | No LS | LS |
|---|---|---|
| 2–4 ABVD/AVD | 24 | 9 |
| >4 ABVD/AVD | 22 | 11 |
| ≥6 R-CHOP | 2 | 1 |
| ≥6 R-EPOCH | 6 | 2 |
| ≥6 HyperCVAD | 1 | 0 |
| Salvage | 20 | 7 |
ABVD/AVD: Doxorubicin, Bleomycin, Vinblastine, Dacarbazine
R-CHOP: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone
R-EPOCH: Rituximab, Etoposide, Prednisolone, Vincristin, Cyclophosphamide, Doxorubicin
HyperCVAD: Cyclophosphamide, Vincristine, Doxorubicin, Dexamethasone, Methotrexate, Cytarabine
Salvage: Multiple lines of chemotherapy +/− Stem cell transplantation